Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1451
WisdomTree US SmallCap Dividend Fund
DES
$2.07B
| $115M | 0.01% |
2,828,155
+64,777
| +2% | +$2.5M |
2013 Q2
52 quarters
|
|
1452
Owens Corning
OC
$8.99B
| $115M | 0.01% |
723,481
-102,397
| -12% | -$12.4M |
2013 Q2
52 quarters
|
|
1453
Tarsus Pharmaceuticals
TARS
$3.32B
| $115M | 0.01% |
1,827,082
-117,190
| -6% | -$7.49M |
2021 Q2
20 quarters
|
|
1454
JPMorgan ActiveBuilders Emerging Markets Equity ETF
JEMA
$1.68B
| $115M | 0.01% |
1,800,049
-1,684,611
| -48% | -$102M |
2022 Q4
14 quarters
|
|
1455
Sun Communities
SUI
$14.1B
| $115M | 0.01% |
957,254
+150,612
| +19% | +$18.8M |
2013 Q2
52 quarters
|
|
1456
Calvert Ultra-Short Investment Grade ETF
CVSB
$273M
| $115M | 0.01% |
2,265,063
+54,905
| +2% | +$2.78M |
2023 Q1
13 quarters
|
|
1457
iShares Morningstar Mid-Cap ETF
IMCB
$1.71B
| $114M | 0.01% |
1,185,395
-323,586
| -21% | -$29.6M |
2013 Q2
52 quarters
|
|
1458
Diodes
DIOD
$3.93B
| $114M | 0.01% |
1,045,681
-618,845
| -37% | -$62.8M |
2013 Q2
52 quarters
|
|
1459
Life Time Group Holdings
LTH
$9.06B
| $114M | 0.01% |
2,801,545
+584,087
| +26% | +$18.5M |
2021 Q4
18 quarters
|
|
1460
Aecom
ACM
$7.6B
| $114M | 0.01% |
1,638,429
-41,040
| -2% | -$3.14M |
2013 Q2
52 quarters
|
|
1461
ServiceTitan Inc
TTAN
$7.34B
| $114M | 0.01% |
1,612,516
+803,948
| +99% | +$51.8M |
2024 Q4
6 quarters
|
|
1462
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.04B
| $114M | 0.01% |
825,868
+37,999
| +5% | +$4.82M |
2013 Q2
52 quarters
|
|
1463
IES Holdings
IESC
$11.1B
| $113M | 0.01% |
308,442
-46,738
| -13% | -$15.1M |
2013 Q3
51 quarters
|
|
1464
MYR Group
MYRG
$4.45B
| $113M | 0.01% |
226,244
+18,122
| +9% | +$7.44M |
2013 Q2
52 quarters
|
|
1465
Stoke Therapeutics
STOK
$1.59B
| $113M | 0.01% |
3,452,795
+29,515
| +0.9% | +$947K |
2019 Q2
28 quarters
|
|
1466
Community Bank
CBU
$3.14B
| $113M | 0.01% |
1,682,284
-178,802
| -10% | -$11.3M |
2013 Q2
52 quarters
|
|
1467
Fidelity Blue Chip Growth ETF
FBCG
$7.5B
| $113M | 0.01% |
1,817,581
+243,367
| +15% | +$14.4M |
2020 Q4
22 quarters
|
|
1468
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.18B
| $113M | 0.01% |
5,778,792
-179,273
| -3% | -$3.5M |
2017 Q2
36 quarters
|
|
1469
Acushnet Holdings
GOLF
$4.64B
| $113M | 0.01% |
951,839
-159,722
| -14% | -$15.3M |
2016 Q4
38 quarters
|
|
1470
DigitalOcean
DOCN
$12.9B
| $113M | 0.01% |
717,187
-170,798
| -19% | -$23.1M |
2021 Q1
21 quarters
|
|
1471
VanEck Pharmaceutical ETF
PPH
$1.07B
| $112M | 0.01% |
1,028,317
+850,470
| +478% | +$88M |
2013 Q2
52 quarters
|
|
1472
Taysha Gene Therapies
TSHA
$1.22B
| $112M | 0.01% |
16,487,479
-1,477,892
| -8% | -$8.75M |
2020 Q4
22 quarters
|
|
1473
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$2.9B
| $112M | 0.01% |
2,450,023
-693,561
| -22% | -$31.6M |
2013 Q2
52 quarters
|
|
1474
FNB Corp
FNB
$6.11B
| $112M | 0.01% |
5,879,004
+643,809
| +12% | +$11.5M |
2013 Q2
52 quarters
|
|
1475
Takeda Pharmaceutical
TAK
$62.1B
| $112M | 0.01% |
6,994,924
+525,324
| +8% | +$8.69M |
2018 Q4
30 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.